A
AZTR
Azitra Inc
0.2123
+0.0081+3.94%Pre Market: 0.2154 +0.0031 +1.46%06:42 06/10 EDT
OPEN/PREV CLOSE0.1995/0.2043
TODAY RANGE0.1995-0.2145
VOL7.84K
MARKET CAP3.44M
52 WEEK RANGE0.1000-2.398
AVG VOL (3M)11.53M
% TURNOVER2.26%
TURNOVER116.89K
P/E (TTM)-0.0919
% RANGE7.05%
EPS(TTM)-2.3107
P/E(FORWARD)-0.8165
P/B0.3280
BVPS0.6472
DIVIDEND--
P/S31.06
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.32M
SHARES OUTSTANDING16.19M
NEXT EARNINGS--
FREE FLOAT15.65M
LOT SIZE1
EX-DATE08/21/2025
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Azitra Adjourns 2026 Annual Meeting for Lack of Quorum
TipRanks·05/27 21:49
Azitra Adjusts 2026 Annual Shareholders Meeting Schedule
PR Newswire·05/27 20:30
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
TipRanks·05/21 21:00
Azitra files to sell 255.7M shares of common stock for holders
TipRanks·05/14 19:10
Analysts’ Top Healthcare Picks: Candel Therapeutics (CADL), Azitra Inc (AZTR)
Seeking Alpha·05/13 14:08
Azitra GAAP EPS of -$0.25
Benzinga·05/13 12:54
Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate
Dow Jones·05/13 12:31
*Azitra 1Q Loss/Shr 25c >AZTR
Dow Jones·05/13 12:30
Press Release: Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
Dow Jones·05/13 12:30
Press Release: Azitra, Inc. Announces Q1 2026 -2-
Press release·05/13 12:10
AZITRA, INC. (Form 10-Q)
TipRanks·05/07 06:25
Azitra granted new U.S. patent protecting ATR-12 program
Seeking Alpha·05/06 12:50
Azitra secures U.S. patent for ATR-12 skin disease treatment program
Same Industry
Name/Symbol
Change%
Price